PMBLive Canada

Home / Technology

Taking Weekends Off Dasatinib Maintains Responses in First-Line CML

Targeted Onc ·

Taking Weekends Off Dasatinib Maintains Responses in First-Line CML

The phase 3 DasaHIT trial found that weekend dasatinib breaks maintained CML responses in first-line patients, with fewer effusions in exploratory analyses.

More from Technology

More →